Alessandra Raimondi

Presentation(s):

• SO-21: Optimal maintenance treatment strategy following an anti-EGFR-based first-line induction therapy in patients with RAS wild type metastatic colorectal cancer: an individual patient data pooled analysis of clinical trials

  Friday, July 1, 2022
  08:58 – 09:09